Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy

IMPORTANCE: The magnitude of risk of pregnancy-related multiple sclerosis relapses, particularly severe relapses, following natalizumab cessation is unclear, as is whether this risk is reduced by pregnancy or other modifiable factors. OBJECTIVE: To determine the association of early natalizumab with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellwig, Kerstin, Tokic, Marianne, Thiel, Sandra, Esters, Nina, Spicher, Charlotte, Timmesfeld, Nina, Ciplea, Andrea I., Gold, Ralf, Langer-Gould, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787598/
https://www.ncbi.nlm.nih.gov/pubmed/35072719
http://dx.doi.org/10.1001/jamanetworkopen.2021.44750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787598/
https://www.ncbi.nlm.nih.gov/pubmed/35072719
http://dx.doi.org/10.1001/jamanetworkopen.2021.44750

Ejemplares similares